Changes in brain activation related to visuo-spatial memory after real-time fMRI neurofeedback training in healthy elderly and Alzheimer's disease.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
02 03 2020
Historique:
received: 18 10 2019
revised: 11 12 2019
accepted: 13 12 2019
pubmed: 22 12 2019
medline: 27 5 2021
entrez: 22 12 2019
Statut: ppublish

Résumé

Cognitive decline is a symptom of healthy ageing and Alzheimer's disease. We examined the effect of real-time fMRI based neurofeedback training on visuo-spatial memory and its associated neuronal response. Twelve healthy subjects and nine patients of prodromal Alzheimer's disease were included. The examination spanned five days (T1-T5): T1 contained a neuropsychological pre-test, the encoding of an itinerary and a fMRI-based task related that itinerary. T2-T4 hosted the real-time fMRI neurofeedback training of the parahippocampal gyrus and on T5 a post-test session including encoding of another itinerary and a subsequent fMRI-based task were done. Scores from neuropsychological tests, brain activation and task performance during the fMRI-paradigm were compared between pre and post-test as well as between healthy controls and patients. Behavioural performance in the fMRI-task remained unchanged, while cognitive testing showed improvements in visuo-spatial memory performance. Both groups displayed task-relevant brain activation, which decreased in the right precentral gyrus and left occipital lobe from pre to post-test in controls, but increased in the right occipital lobe, middle frontal gyrus and left frontal lobe in the patient group. While results suggest that the training has affected brain activation differently between controls and patients, there are no pointers towards a behavioural manifestation of these changes. Future research is required on the effects that can be induced using real-time fMRI based neurofeedback training and the required training duration to elicit broad and lasting effects.

Identifiants

pubmed: 31863845
pii: S0166-4328(19)31544-X
doi: 10.1016/j.bbr.2019.112435
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112435

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Christian Hohenfeld (C)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany.

Hanna Kuhn (H)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany; University Hospital Bern, Emergency Department, Bern, Switzerland.

Christine Müller (C)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany; Bethesda Clinic, Department of Neurorehabilitation, Tschugg, Switzerland.

Nils Nellessen (N)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany; University of Cologne, Department of Neurology, Cologne, Germany.

Simon Ketteler (S)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany.

Armin Heinecke (A)

Brain Innovation, Maastricht, The Netherlands.

Rainer Goebel (R)

Netherlands Institute for Neuroscience, Department of Neuroimaging and Neuromodeling, Amsterdam, The Netherlands; Maastricht University, Department of Cognitive Neuroscience, Maastricht, The Netherlands; Brain Innovation, Maastricht, The Netherlands.

N Jon Shah (NJ)

Research Centre Jülich, Institute for Neuroscience and Medicine (INM-4/6), Jülich, Germany; RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany.

Jörg B Schulz (JB)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany.

Martina Reske (M)

Research Centre Jülich, Institute for Neuroscience and Medicine (INM-4/6), Jülich, Germany.

Kathrin Reetz (K)

RWTH Aachen University, Department of Neurology, Aachen, Germany; JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University, Aachen, Germany. Electronic address: kreetz@ukaachen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH